RAB11FIP3

Across TCGA pan-cancer cohorts, RAB11FIP3 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RAB11FIP3’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where RAB11FIP3 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types RAB11FIP3 is over-expressed in tumor, although a few such as CCRCC and LUAD show the opposite, repressed pattern.

CCRCC, LUAD, and HNSC are the cancer types where RAB11FIP3 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RAB11FIP3 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Female	III,IV	−1.125	<.001	12	view →
LUAD	Male	II,III,IV	−0.455	<.001	7	view →
HNSC	All	All	−0.500	.001	5	view →
LSCC	Male	All	−0.399	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RAB11FIP3–CCRCC

Open the CCRCC breakdown →